More Americans Skipped The Doctor Last Year Because Of Costs

The share of Americans who skipped medical treatment last year because of costs rose substantially from the lows of 2020 and 2021, per a Federal Reserve Survey out Monday.

Why it matters: The ability to afford health care often translates into better health.

  • The survey also found that in families with income less than $25,000, 75% reported being in good health, compared with 91% for those with income of $100,000 or more.

Zoom out: Inflation walloped Americans across income levels in 2022, causing many to cut back on spending  and that includes health care, an area people feel they can cut when times are tight.

  • The most commonly skipped form of medical treatment was the dentist, followed by seeing a doctor and paying for a prescription.
  • 35% of Americans said their financial situation was worse in 2022 than the year prior, per the survey. That’s the largest share on record since the Fed started asking the question a decade ago, Axios’ Courtenay Brown reported.

Context: Back in 2020 and 2021, a record low share of Americans skipped medical treatment due to cost, likely because they had more cash in their pockets thanks to COVID-era stimulus, as well as more access to health care — Medicaid coverage was also expanded in the pandemic.

What to watch: If the line on that chart rises more next year. Millions of Americans are expected to lose Medicaid access this year as the pandemic-related expansions end.

  • Those without insurance are twice as likely to skip treatment, the Fed survey found.

 

Source Link

Recommended Articles

New NFIB Survey: Small Businesses Report Reduced Optimism

The NFIB Small Business Optimism Index fell 0.6 points in May to 95.3, remaining below its 52-year average of 98.0. The Uncertainty Index rose 3 points from April to 91, remaining well above its historical average of 68. As reported in NFIB’s monthly Jobs Report, the NFIB Small Business Employment Index remained essentially flat, registering 100.3 in May. ...

Read More

Trump Announces TrumpRx Expansion, Adding 160 More Drugs

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months. “I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” ...

Read More

Skyrocketing GLP-1 Demand Creates Major Financial Strain For Employers

GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...

Read More

Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas

A Trump administration initiative to impose $100,000 fees on employers seeking visas for skilled foreign workers amounts to an unlawful tax on those companies and must be voided “in its entirety,” a federal judge ruled on Monday. The decision by Judge Leo T. Sorokin of the Federal District Court for the District of Massachusetts nullified ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square